Alpha Centric Advisors LLC Mei Pharma, Inc. Transaction History

Alpha Centric Advisors LLC

  • $144 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 25, 2022
SELL
$2.33 - $3.37 $193,390 - $279,710
-83,000 Closed
0 $0
Q3 2021

Mar 09, 2022
BUY
$2.52 - $2.99 $108,360 - $128,570
43,000 Added 107.5%
83,000 $229,000
Q2 2021

Mar 09, 2022
BUY
$2.6 - $3.65 $13,000 - $18,250
5,000 Added 14.29%
40,000 $114,000
Q4 2020

Mar 11, 2022
BUY
$2.6 - $3.32 $91,000 - $116,200
35,000 New
35,000 $92,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $372M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email